On the plus side TLX felt it appropriate to inform the market what was going on. That puts its miles ahead of other clinical stage biotechs that I follow.
Recruitment is largely beyond their control.
Ann: ZIRCON Phase 3 Renal Cancer Imaging Study - Progress Update, page-4
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.47 |
Change
-0.530(2.65%) |
Mkt cap ! $6.515B | |||
| Open | High | Low | Value | Volume |
| $20.47 | $20.76 | $19.46 | $45.80M | 2.319M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 3678 | $19.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.48 | 110 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |